Russia’s exposure to the global financial crisis had become unquestionable by the end of 2008.
After years of dynamic development, a result of the country’s stable economic growth, rising incomes and expansion of modern retail channels, the Russian economy started slowing down to encounter severe after-effects of the economic downturn in 2009.
After [...]
The pharmaceutical market in Central and Eastern Europe is dominated by generic drugs. This subdivision was worth €17.2bn in 2008 and is expected to develop by around 14% per annum between 2009 and 2011.
The growth rate of the innovative drug market, which was worth €12.4bn in 2008, will be slower, according [...]
After the dramatic slump in early 2009, the mood prevailing within the construction industry in Poland is starting to gradually turn more upbeat.
Construction companies are more optimistic in their assessments of the market situation and the condition of their enterprises than they were six months ago. Driven by the rising implementation of [...]
Russian telecommunication operators have been expanding aggressively in the CIS since the early 2000s, but no major deals were recorded in 2008 or 2009.
The move on the part of Russian operators toward business diversification into adjacent areas, uncertainty over the fate of Svyazinvest, the national state-run fixed-line holding, the high cost of telecommunication assets, and, [...]
The construction industry in Russia has been hit hard by the global economic downturn. The slowdown on the domestic construction market began in 2008 and has intensified in 2009.
The majority of construction projects have been suspended and virtually no new residential or commercial property projects have been started. For the [...]
In 2008 the OTC product market in Central and Eastern Europe developed by around 26%, to €9.2bn.
In 2009 this market in the region will grow by around 8%, according to a recently released report “OTC market in Central and Eastern Europe 2009. Comparative analysis and development forecasts for 2009-2011″ from [...]
Today the market for biotechnology which can be used in pharmaceuticals and medicine (“red biotechnology”) is growing at a moderate pace in Poland.
In 2008 the sales of industry players even declined, as Bioton, the largest Polish biotech firm, performed poorly. Biotechnological firms are working hard on new products, the sales of which [...]
August 21, 2009 | Posted in
Emerging Markets |
Read More »
